[go: up one dir, main page]

AU3953899A - Cyclooxygenase-2 inhibitors - Google Patents

Cyclooxygenase-2 inhibitors

Info

Publication number
AU3953899A
AU3953899A AU39538/99A AU3953899A AU3953899A AU 3953899 A AU3953899 A AU 3953899A AU 39538/99 A AU39538/99 A AU 39538/99A AU 3953899 A AU3953899 A AU 3953899A AU 3953899 A AU3953899 A AU 3953899A
Authority
AU
Australia
Prior art keywords
cyclooxygenase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39538/99A
Other languages
English (en)
Inventor
Ayatsugu Nakamura
Mitsushi Tanaka
Masami Tsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of AU3953899A publication Critical patent/AU3953899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39538/99A 1998-05-27 1999-05-26 Cyclooxygenase-2 inhibitors Abandoned AU3953899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10/145518 1998-05-27
JP14551898 1998-05-27
PCT/JP1999/002763 WO1999061016A1 (fr) 1998-05-27 1999-05-26 Inhibiteurs de cyclo-oxygenase-2

Publications (1)

Publication Number Publication Date
AU3953899A true AU3953899A (en) 1999-12-13

Family

ID=15387093

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39538/99A Abandoned AU3953899A (en) 1998-05-27 1999-05-26 Cyclooxygenase-2 inhibitors

Country Status (2)

Country Link
AU (1) AU3953899A (fr)
WO (1) WO1999061016A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6353016B1 (en) * 1998-01-14 2002-03-05 Nippon Shinyaku Co., Ltd. Potassium channel activators
EP1175214B1 (fr) 1999-12-08 2004-11-24 Pharmacia Corporation Compositions d'inhibiteur de cyclooxygenase-2 produisant rapidement un effet therapeutique
DE10001166A1 (de) * 2000-01-13 2001-07-19 Merckle Gmbh Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung
PT1572173E (pt) * 2002-12-13 2010-05-10 Warner Lambert Co Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
PL2266585T3 (pl) 2003-05-07 2013-10-31 Osteologix As Rozpuszczalne w wodzie sole stronktu do stosowania w leczeniu chorób chrząstki i/lub kości

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2166941C2 (ru) * 1995-06-07 2001-05-20 Ниппон Синяку Ко., Лтд. Производные пиррола и фармацевтическая композиция на их основе
US5908858A (en) * 1996-04-05 1999-06-01 Sankyo Company, Limited 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
WO1998002430A1 (fr) * 1996-07-11 1998-01-22 Pfizer Pharmaceuticals Inc. Composes de pyridylpyrrole utiles comme antagonistes de l'interleukine et du facteur tnf

Also Published As

Publication number Publication date
WO1999061016A1 (fr) 1999-12-02

Similar Documents

Publication Publication Date Title
AU2001258771A1 (en) -secretase inhibitors
AU6477498A (en) Scale inhibitors
AU3102397A (en) Metalloprotease inhibitors
AU6229699A (en) Beta-amyloid formation inhibitors
AU5991699A (en) Quinolizinones as integrin inhibitors
AU4723799A (en) Protease inhibitors
AU9059798A (en) Urokinase inhibitors
AU4092799A (en) Protease inhibitors
AU4685799A (en) Telomerase inhibitors
AU1703799A (en) Cyclooxygenase-2 inhibition
AU9110298A (en) Protease inhibitors
AU1393900A (en) Morpholino-ethoxybenzofuran protease inhibitors
AU3235100A (en) Prothease inhibitors
AU4564499A (en) Protease inhibitors
AU2713100A (en) Protease inhibitors
AU7957000A (en) Cyclooxygenase-2 expression inhibitors
AU5516599A (en) Substituted 3-aryl-pyrazoles
AU3953899A (en) Cyclooxygenase-2 inhibitors
AU4507899A (en) Substituted n-aryl-o-alkyl-carbamates
AU1057000A (en) Carrying aid
AU4511499A (en) Substituted cyclooctadepsipeptides
AU1055399A (en) Rollerboard
AU6079199A (en) Sialyltransferase inhibitors
AU5860999A (en) Herbicidal method
AU6843598A (en) Metalloproteinase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase